⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL140067 | 1.00 | — | — | |
| SCHEMBL8846452 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL30939140 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL22287292 | 0.97 | — | — | |
| Ammonia Solution, Strong SCHEMBL7663383 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL2520308 | 0.97 | — | — | |
| Formic Acid SCHEMBL4623888 | 0.87 | TSHR (0.42) | — | |
| SCHEMBL10363139 | 0.83 | TSHR (0.39) | — | |
| SCHEMBL26618612 | 0.81 | — | — | |
| SCHEMBL3309787 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250282725-A1 | KCNQ POTENTIATORS | Eii Lilly and Company | 2025-09-11 | — | — | US | disclosed |
| US-12344584-B2 | KCNQ potentiators | ELI LILLY AND COMPANY (US) | 2025-07-01 | — | — | US | disclosed |
| US-20240076269-A1 | KCNQ POTENTIATORS | Eii Lilly and Company (US) | 2024-03-07 | — | — | US | disclosed |
| US-11840516-B2 | KCNQ potentiators | ELI LILLY AND COMPANY (US) | 2023-12-12 | — | — | US | disclosed |
| US-11840516-B2 | KCNQ potentiators | ELI LILLY AND COMPANY (US) | 2023-12-12 | — | — | US | disclosed |
| US-11840516-B2 | KCNQ potentiators | ELI LILLY AND COMPANY (US) | 2023-12-12 | — | — | US | disclosed |
| EP-3921030-B1 | 1-((2-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-4-YL)METHYL)UREA DERIVATIVES AS KCNQ POTENTIATORS | LILLY CO ELI (US) | 2023-10-11 | — | — | EP | disclosed |
| EP-3921030-B1 | 1-((2-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-4-YL)METHYL)UREA DERIVATIVES AS KCNQ POTENTIATORS | LILLY CO ELI (US) | 2023-10-11 | — | — | EP | disclosed |
| US-20220073464-A1 | KCNQ POTENTIATORS | ELI LILLY AND COMPANY | 2022-03-10 | — | — | US | disclosed |
| US-20220073464-A1 | KCNQ POTENTIATORS | ELI LILLY AND COMPANY | 2022-03-10 | — | — | US | disclosed |
| CN-113692304-A | 1- ((2- (2,2, 2-trifluoroethoxy) pyridin-4-yl) methyl) urea derivatives as KCNQ enhancers | 礼来公司 | 2021-11-23 | — | — | CN | disclosed |
| WO-2020163268-A1 | 1-((2-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-4-YL)METHYL)UREA DERIVATIVES AS KCNQ POTENTIATORS | ELI LILLY AND COMPANY (US) | 2020-08-13 | — | — | WO | disclosed |
| WO-2020163268-A1 | 1-((2-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-4-YL)METHYL)UREA DERIVATIVES AS KCNQ POTENTIATORS | ELI LILLY AND COMPANY (US) | 2020-08-13 | — | — | WO | disclosed |
| US-20200247752-A1 | KCNQ Potentiators | ELI LILLY AND COMPANY (US) | 2020-08-06 | — | — | US | disclosed |
| US-20200247752-A1 | KCNQ Potentiators | ELI LILLY AND COMPANY (US) | 2020-08-06 | — | — | US | disclosed |
| EP-0910564-B1 | D-AMINO ACID DERIVED INHIBITORS OF CYSTEINE AND SERINE PROTEASES | CEPHALON INC (US) | 2007-10-31 | — | — | EP | disclosed |
| EP-0910564-A4 | — | — | 1999-04-28 | — | — | EP | disclosed |
| EP-0910564-A1 | D-AMINO ACID DERIVED INHIBITORS OF CYSTEINE AND SERINE PROTEASES | CEPHALON, INC. (US) | 1999-04-28 | — | — | EP | disclosed |
| US-5852007-A | Cysteine and serine protease inhibitors containing D-amino acid at the P2 position, methods of making same, and methods of using same | CEPHALON, INC. (US) | 1998-12-22 | — | — | US | disclosed |
| WO-1997021690-A1 | D-AMINO ACID DERIVED INHIBITORS OF CYSTEINE AND SERINE PROTEASES | CEPHALON, INC. (US) | 1997-06-19 | — | — | WO | disclosed |